AI, Privacy, & Genomics: The Next Era of Drug Design

2020 has shed light on the unacknowledged void present in the drug manufacturing system despite the technological preferment and reduced period between the proposed drug and its availability on the shelf. This report studies recent developments in both Artificial Intelligence (AI) and drug R&D. In addition to this, it discusses the crucial role AI will play and how its relation to available genetic data can shape how the industry works while keeping in check the importance of AI privacy and how multiparty access will deal with it. To find out more about the privacy issues and solutions involved in AI and genomics, here is the link to the full report: https://www.dgen.org/ai-privacy-and-genomics